These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36815259)

  • 41. Asymptomatic Myocarditis with Mild Cardiac Marker Elevation Following Nivolumab-Induced Myositis.
    Shindo A; Yamasaki M; Uchino K; Yamasaki M
    Int Heart J; 2022; 63(1):180-183. PubMed ID: 35095069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune checkpoint inhibitor-related myositis and myocarditis with multiple myositis-specific/-associated antibodies.
    Isa M; Hongo Y; Sakamoto N; Yamazaki K; Takazaki H; Asakuma J; Ikewaki K; Suzuki K
    J Neurol Sci; 2023 Jan; 444():120528. PubMed ID: 36565689
    [No Abstract]   [Full Text] [Related]  

  • 43. Emerging role of immune checkpoint inhibitors and their relevance for the cardiovascular system.
    Michel L; Totzeck M; Lehmann L; Finke D
    Herz; 2020 Nov; 45(7):645-651. PubMed ID: 32533218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune checkpoint inhibitor-associated myocarditis and coronary artery disease: There may be more than meets the eye!
    Maria ATJ; Delmas C; Coustal C; Palassin P; Roubille F
    Eur J Cancer; 2022 Dec; 177():194-196. PubMed ID: 36809166
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy.
    Balanescu DV; Donisan T; Palaskas N; Lopez-Mattei J; Kim PY; Buja LM; McNamara DM; Kobashigawa JA; Durand JB; Iliescu CA
    Cardiovasc Pathol; 2020; 47():107211. PubMed ID: 32268262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune Checkpoint Inhibitor-Related Myocarditis: Recognition, Surveillance, and Management.
    Kuhnly NM; Coviello J
    Clin J Oncol Nurs; 2022 Feb; 26(1):54-60. PubMed ID: 35073300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune checkpoint inhibitor-associated myasthenia gravis, myositis, and myocarditis overlap syndrome.
    Lipe DN; Galvis-Carvajal E; Rajha E; Wechsler AH; Gaeta S
    Am J Emerg Med; 2021 Aug; 46():51-55. PubMed ID: 33721590
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression.
    Mohammad KO; Fanous H; Vakamudi S; Liu Y
    Cardiooncology; 2023 Mar; 9(1):15. PubMed ID: 36941689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nivolumab-associated myositis myocarditis and myasthenia and anti-striated muscle antibodies.
    Fazal M; Prentice DA; Kho LK; Fysh E
    Intern Med J; 2020 Aug; 50(8):1003-1006. PubMed ID: 33306231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immune Checkpoint Inhibitor-Associated Primary Adrenal Insufficiency: WHO VigiBase Report Analysis.
    Grouthier V; Lebrun-Vignes B; Moey M; Johnson DB; Moslehi JJ; Salem JE; Bachelot A
    Oncologist; 2020 Aug; 25(8):696-701. PubMed ID: 32390168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A case of asymptomatic immune checkpoint inhibitor associated myocarditis and myositis].
    Wang F; Gong XL; Geng HY; Cheng Y; Chen XN
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Nov; 50(11):1103-1105. PubMed ID: 36418279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis.
    Siddiqui BA; Palaskas NL; Basu S; Dai Y; He Z; Yadav SS; Allison JP; Sheth RA; Tummala S; Buja M; Bhattacharjee MB; Iliescu C; Rawther-Karedath A; Deswal A; Wang L; Sharma P; Subudhi SK
    Cancer Immunol Res; 2024 Aug; 12(8):964-987. PubMed ID: 38768394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myocarditis related to immune checkpoint inhibitors treatment: two case reports and literature review.
    Chen Y; Jia Y; Liu Q; Shen Y; Zhu H; Dong X; Huang J; Lu J; Yin Q
    Ann Palliat Med; 2021 Jul; 10(7):8512-8517. PubMed ID: 34263614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prognostic value of global myocardium strain by CMR-feature tracking in immune checkpoint inhibitor-associated myocarditis.
    Zhao SH; Yun H; Chen CZ; Chen YY; Lin JY; Zeng MS; Liu TS; Pan CZ; Jin H
    Eur Radiol; 2022 Nov; 32(11):7657-7667. PubMed ID: 35567603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis.
    Cautela J; Zeriouh S; Gaubert M; Bonello L; Laine M; Peyrol M; Paganelli F; Lalevee N; Barlesi F; Thuny F
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33298621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy.
    Palaskas NL; Segura A; Lelenwa L; Siddiqui BA; Subudhi SK; Lopez-Mattei J; Durand JB; Deswal A; Zhao B; Maximilian Buja L; Iliescu C
    Eur J Heart Fail; 2021 Oct; 23(10):1725-1735. PubMed ID: 34114291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune checkpoint inhibitor toxicity: A new indication for therapeutic plasma exchange?
    Compton F; He L; Sarode R; Wodajo A; Usmani A; Burner J; Berlacher M; De Simone N
    J Clin Apher; 2021 Aug; 36(4):645-648. PubMed ID: 33648026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation.
    Valenti-Azcarate R; Esparragosa Vazquez I; Toledano Illan C; Idoate Gastearena MA; Gállego Pérez-Larraya J
    Neuromuscul Disord; 2020 Jan; 30(1):67-69. PubMed ID: 31839404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A retrospective study of immune checkpoint inhibitor-associated myocarditis in a single center in China.
    Wang F; Sun X; Qin S; Hua H; Liu X; Yang L; Yang M
    Chin Clin Oncol; 2020 Apr; 9(2):16. PubMed ID: 32279526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Teriprizumab-induced myocarditis in a patient with cholangiocarcinoma: a case report.
    Ye Y; Li Y; Zhang S; Han G
    J Int Med Res; 2022 Oct; 50(10):3000605221133259. PubMed ID: 36300305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.